Related Experiment Video
Updated: Feb 25, 2026

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes
Published on: January 16, 2015
Polycomb Repressor Complex 2 in Genomic Instability and Cancer
Zoe Veneti1, Kalliopi K Gkouskou2,3, Aristides G Eliopoulos4,5
1Molecular and Cellular Biology Laboratory, Division of Basic Sciences, University of Crete Medical School, 71003 Heraklion, Greece. veneti@imbb.forth.gr.
Abstract:
Polycomb repressor complexes PRC1 and PRC2 regulate chromatin compaction and gene expression, and are widely recognized for their fundamental contributions to developmental processes. Herein, we summarize the existing evidence and molecular mechanisms linking PRC-mediated epigenetic aberrations to genomic instability and malignancy, with a particular focus on the role of deregulated PRC2 in tumor suppressor gene expression, the DNA damage response, and the fidelity of DNA replication. We also discuss some of the recent advances in the development of pharmacological and dietary interventions affecting PRC2, which point to promising applications for the prevention and management of human malignancies.
Insights
Polycomb repressor complexes (PRC) are crucial for development. Aberrant PRC2 function links to cancer by affecting gene expression, DNA repair, and replication, with potential therapeutic interventions emerging.
Area of Science:
- Epigenetics and Gene Regulation
- Cancer Biology
- Chromatin Dynamics
Background:
- Polycomb repressor complexes (PRC1 and PRC2) are key epigenetic regulators of gene expression and chromatin structure.
- These complexes play vital roles in normal development.
- Dysregulation of PRC complexes is increasingly implicated in various diseases, particularly cancer.
Purpose of the Study:
- To review the molecular mechanisms linking Polycomb repressor complex (PRC)-mediated epigenetic alterations to genomic instability and cancer.
- To highlight the specific role of deregulated PRC2 in tumor suppressor gene silencing, DNA damage response, and replication fidelity.
- To discuss emerging therapeutic strategies targeting PRC2 for cancer prevention and treatment.
Main Methods:
- Literature review and synthesis of existing evidence.
- Analysis of molecular mechanisms underlying PRC function in epigenetics and cancer.
- Discussion of recent advancements in pharmacological and dietary interventions targeting PRC2.
Main Results:
- Epigenetic aberrations driven by PRC complexes, especially PRC2, are linked to genomic instability and malignancy.
- Deregulated PRC2 activity impacts tumor suppressor gene expression, DNA damage response pathways, and DNA replication fidelity.
- Emerging interventions targeting PRC2 show promise for cancer management.
Conclusions:
- PRC-mediated epigenetic dysregulation is a significant factor in the development of genomic instability and cancer.
- Targeting PRC2 offers a promising avenue for novel cancer therapies.
- Further research into PRC2 functions and interventions could lead to effective strategies for cancer prevention and treatment.
Related Concept Videos
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Induced Pluripotent Stem Cells
Somatic...
Nucleosome Remodeling
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

